Drug and Alcohol Dependence response to KK-21-1460 “Considering rationales for use in defining subgroups for the treatment of stimulant use disorder”

Brian Chan; Michele Freeman; Chelsea Ayers; P. Korthuis; Robin Paynter; Karli Kondo; Devan Kansagara

doi:10.1016/j.drugalcdep.2021.108571

Drug and Alcohol Dependence response to KK-21-1460 “Considering rationales for use in defining subgroups for the treatment of stimulant use disorder”

Brian Chan, Michele Freeman, Chelsea Ayers, P. Korthuis, Robin Paynter, Karli Kondo, Devan Kansagara

Research output: Contribution to journal › Letter › peer-review

Original language	English (US)
Article number	108571
Journal	Drug and Alcohol Dependence
Volume	221
DOIs	https://doi.org/10.1016/j.drugalcdep.2021.108571
State	Published - Apr 1 2021

ASJC Scopus subject areas

Toxicology
Pharmacology
Psychiatry and Mental health
Pharmacology (medical)

Access to Document

10.1016/j.drugalcdep.2021.108571

Cite this

Drug and Alcohol Dependence response to KK-21-1460 “Considering rationales for use in defining subgroups for the treatment of stimulant use disorder”. / Chan, Brian; Freeman, Michele; Ayers, Chelsea; Korthuis, P.; Paynter, Robin; Kondo, Karli; Kansagara, Devan.

In: Drug and Alcohol Dependence, Vol. 221, 108571, 01.04.2021.

Research output: Contribution to journal › Letter › peer-review

@article{865ee6725d5e42afbf8d6a2ff271d432,

title = "Drug and Alcohol Dependence response to KK-21-1460 “Considering rationales for use in defining subgroups for the treatment of stimulant use disorder”",

author = "Brian Chan and Michele Freeman and Chelsea Ayers and P. Korthuis and Robin Paynter and Karli Kondo and Devan Kansagara",

note = "Funding Information: This research was funded by the Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Quality Enhancement Research Initiative, Evidence Synthesis Program (#05-225).Dr. Chan's time was supported by AHRQ PCOR K12Dr. Korthuis? time was supported by the National Institutes of Health, National Institute on Drug Abuse (UG1DA015815, UG3DA044831).",

year = "2021",

month = apr,

day = "1",

doi = "10.1016/j.drugalcdep.2021.108571",

language = "English (US)",

volume = "221",

journal = "Drug and Alcohol Dependence",

issn = "0376-8716",

publisher = "Elsevier Ireland Ltd",

}

TY - JOUR

T1 - Drug and Alcohol Dependence response to KK-21-1460 “Considering rationales for use in defining subgroups for the treatment of stimulant use disorder”

AU - Chan, Brian

AU - Freeman, Michele

AU - Ayers, Chelsea

AU - Korthuis, P.

AU - Paynter, Robin

AU - Kondo, Karli

AU - Kansagara, Devan

N1 - Funding Information: This research was funded by the Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Quality Enhancement Research Initiative, Evidence Synthesis Program (#05-225).Dr. Chan's time was supported by AHRQ PCOR K12Dr. Korthuis? time was supported by the National Institutes of Health, National Institute on Drug Abuse (UG1DA015815, UG3DA044831).

PY - 2021/4/1

Y1 - 2021/4/1

UR - http://www.scopus.com/inward/record.url?scp=85101687299&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85101687299&partnerID=8YFLogxK

U2 - 10.1016/j.drugalcdep.2021.108571

DO - 10.1016/j.drugalcdep.2021.108571

M3 - Letter

C2 - 33597113

AN - SCOPUS:85101687299

VL - 221

JO - Drug and Alcohol Dependence

JF - Drug and Alcohol Dependence

SN - 0376-8716

M1 - 108571

ER -

Drug and Alcohol Dependence response to KK-21-1460 “Considering rationales for use in defining subgroups for the treatment of stimulant use disorder”

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this